Renal Cancer
Preclinical evidence that trametinib enhances the response to anti-angiogenic tyrosine kinase inhibitors in renal cell carcinoma
October 27, 2015
Genomic characterisation of two cancers of unknown primary cases supports a kidney cancer origin
October 26, 2015
The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy
October 21, 2015
IL-37 mediates the antitumor activity in renal cell carcinoma
October 21, 2015
Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status
October 21, 2015
[A pilot study of sunitinib as first-line therapy for metastatic renal cell carcinoma on a 2 weeks on/1 week off intermittent dosing schedule]
October 21, 2015
Management of Small Renal Masses in the Older Adult
October 19, 2015
[Bevacizumab as first-line therapy in metastatic renal cell carcinoma : Progression-free survival for 3 years]
October 19, 2015
PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis
October 19, 2015